Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5976
Vanguard US Multifactor ETF
VFMF
$931M
| $1.39M | ﹤0.01% |
+14,058
| New | +$1.43M |
|
|
DEA
5977
PUT
Easterly Government Properties
DEA
$1.16B
| $1.39M | ﹤0.01% |
40,520
+25,920
| +178% | +$972K |
|
5978
CALL
Pliant Therapeutics
PLRX
$68.1M
| $1.39M | ﹤0.01% |
52,300
+15,400
| +42% | +$438K |
|
5979
CALL
Intellia Therapeutics
NTLA
$1.69B
| $1.39M | ﹤0.01% |
37,300
-39,700
| -52% | -$1.56M |
|
5980
CALL
Amprius Technologies
AMPX
$1.69B
| $1.39M | ﹤0.01% |
159,600
+1,800
| +1% | +$11.4K |
|
5981
PUT
iShares US Financial Services ETF
IYG
$2.22B
| $1.39M | ﹤0.01% |
27,600
+20,700
| +300% | +$1.13M |
|
|
NVRO
5982
CALL
DELISTED
NEVRO CORP.
NVRO
| $1.39M | ﹤0.01% |
38,400
+700
| +2% | +$24.6K |
|
|
GES
5983
PUT
DELISTED
Guess Inc
GES
| $1.39M | ﹤0.01% |
71,300
-51,400
| -42% | -$1.1M |
|
5984
CALL
CMS Energy
CMS
$22.4B
| $1.39M | ﹤0.01% |
22,600
+10,300
| +84% | +$633K |
|
5985
First Trust Indxx Metaverse ETF
ARVR
$5.75M
| $1.39M | ﹤0.01% |
47,172
-2,143
| -4% | -$58.6K |
|
|
SCHR
5986
PUT
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.4B
| $1.39M | ﹤0.01% |
+55,000
| New | +$1.37M |
|
5987
Kiniksa Pharmaceuticals
KNSA
$6.18B
| $1.39M | ﹤0.01% |
128,812
-88,288
| -41% | -$1.16M |
|
5988
Lakeland Financial Corp
LKFN
$1.54B
| $1.38M | ﹤0.01% |
22,110
-65,895
| -75% | -$4.6M |
|
5989
Vital Farms
VITL
$479M
| $1.38M | ﹤0.01% |
90,428
+81,750
| +942% | +$1.29M |
|
5990
LeMaitre Vascular
LMAT
$1.89B
| $1.38M | ﹤0.01% |
+26,879
| New | +$1.3M |
|
|
EVA
5991
PUT
DELISTED
Enviva Inc.
EVA
| $1.38M | ﹤0.01% |
47,900
+31,600
| +194% | +$1.29M |
|
5992
PUT
Ionis Pharmaceuticals
IONS
$9.74B
| $1.38M | ﹤0.01% |
38,700
+15,500
| +67% | +$582K |
|
5993
PUT
Lightwave Logic
LWLG
$1.14B
| $1.38M | ﹤0.01% |
264,400
-122,700
| -32% | -$684K |
|
5994
CALL
NeoGenomics
NEO
$2.08B
| $1.38M | ﹤0.01% |
79,400
+56,800
| +251% | +$809K |
|
5995
Goldman Sachs MarketBeta Emerging Markets Equity ETF
GSEE
$139M
| $1.38M | ﹤0.01% |
34,186
-135,568
| -80% | -$5.58M |
|
5996
CALL
Xenon Pharmaceuticals
XENE
$6.03B
| $1.38M | ﹤0.01% |
38,600
+8,600
| +29% | +$318K |
|
5997
State Street SPDR S&P 1500 Momentum Tilt ETF
MMTM
$165M
| $1.38M | ﹤0.01% |
+8,174
| New | +$1.38M |
|
5998
State Street SPDR S&P Global Infrastructure ETF
GII
$926M
| $1.38M | ﹤0.01% |
+25,334
| New | +$1.37M |
|
5999
BlackLine
BL
$1.7B
| $1.38M | ﹤0.01% |
20,549
-104,998
| -84% | -$7.24M |
|
6000
Radiant Logistics
RLGT
$406M
| $1.38M | ﹤0.01% |
210,203
-77,777
| -27% | -$435K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.